Heidi Hamm

Heidi Hamm, PhD
May 8, 2025

Heidi Hamm, Eric Skaar elected members of the National Academy of Sciences

Hamm and Skaar are among 120 voting members and 30 international members of the NAS whose elections were announced on April 29.

By Bill Snyder
From left, Sheila Collins, PhD, Ryan Ceddia, PhD, and Heidi Hamm, PhD, and their colleagues have identified a potential new approach to reducing the global impact of obesity and diabetes. (photo by Erin O. Smith)
September 6, 2023

Releasing a brake that drives obesity and diabetes

Vanderbilt researchers have uncovered a potential new way to help curb the rapidly rising worldwide prevalence of metabolic disorders, including obesity and diabetes.

By Bill Snyder
March 7, 2019

Vanderbilt scientists report new modeling of brain signaling

The release of neurotransmitters and hormones in the body is tightly controlled by complex protein machinery embedded in cell membranes.

By Bill Snyder
November 23, 2016

Reducing antidepressants’ side effects

Vanderbilt investigators have discovered how antidepressant medicines that block serotonin uptake can increase bleeding risk.

By VUMC News and Communications
January 15, 2015

VUMC investigators honored by ASPET

Vanderbilt’s Heidi Hamm, Ph.D., and L. Jackson Roberts II, M.D., have been lauded by the American Society for Pharmacology and Experimental Therapeutics (ASPET).

By Bill Snyder
June 19, 2014

Hamm’s lasting impact commended at Flexner Discovery Lecture

By Bill Snyder
June 12, 2014

Pharmacology reached new heights on Hamm’s watch

During her 13-year tenure as chair of Vanderbilt University’s Department of Pharmacology, Heidi Hamm, Ph.D., bolstered its international reputation, attracted 18 new faculty members and helped take it in new directions, such as drug discovery.
By VUMC News and Communications
June 5, 2014

Hamm to deliver Discovery Lecture June 12

Heidi Hamm, Ph.D., the Aileen M. Lange and Annie Mary Lyle Professor of Cardiovascular Research and an internationally known expert on G protein-mediated signaling, will deliver the next Flexner Discovery Lecture on Thursday, June 12.
By Bill Snyder
December 2, 2013

VU researchers report G protein advancement that could lead to more effective drugs

Thanks in part to a computer program named “Rosetta,” Vanderbilt University researchers are closer to understanding how the ubiquitous G protein is activated – a discovery that could lead to the design of more specific and effective drugs.
By Bill Snyder
October 25, 2012

Hamm’s research honored by Dutch pharmacology society

Heidi Hamm, Ph.D., chair of the Department of Pharmacology, has won the 2012 Ariens Award from the Dutch Pharmacological Society.
By Bill Snyder
October 18, 2012

Nobel in Chemistry reveals VU ties that bind

Several Vanderbilt researchers have collaborated with this year's Nobel Chemistry winners.
By Bill Snyder